Literature DB >> 23217448

Adherence to pancreatic enzyme supplementation in adolescents with cystic fibrosis.

Colleen Faulkner1, L Janette Taper, Marjorie Scott.   

Abstract

PURPOSE: Levels of adherence to pancreatic enzyme supplementation were investigated in Atlantic Canada adolescents with cystic fibrosis (CF).
METHODS: Participants were recruited from CF clinics at the Izaak Walton Killam Health Centre in Halifax, Nova Scotia, and the Janeway Children's Health & Rehabilitation Centre in St. John's, Newfoundland and Labrador. Self-report questionnaires were mailed to potential participants (n=51) by clinic staff and completed surveys (n=9) were mailed to the principal investigator.
RESULTS: Nine adolescents (mean age 15.2 ± 1.9 years) participated in the study. The adherence survey indicated that the majority perceived themselves to be adherent to taking enzymes with meals (67%), but only 44% perceived themselves to be adherent to taking enzymes with snacks. Recorded amounts of enzymes, taken over three days, indicated that 67% of participants were actually adherent to taking enzymes with meals and 56% with snacks. Including those who correctly predicted non-adherence, 56% and 44% of participants accurately predicted their adherence to taking enzymes with meals and snacks, respectively.
CONCLUSIONS: Adherence rates in the literature vary because of differences in definition and measurement. In the CF population, adherence has been shown to have a positive effect on quality of life. Results for this small group of patients suggest that Atlantic Canada adolescents with CF are able to estimate correctly their adherence to taking pancreatic enzymes, but definite conclusions cannot be made because of the small number of respondents.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23217448     DOI: 10.3148/73.4.2012.196

Source DB:  PubMed          Journal:  Can J Diet Pract Res        ISSN: 1486-3847            Impact factor:   0.940


  2 in total

1.  Adherence to Nutritional Supplementation in Cystic Fibrosis.

Authors:  Kevin A Hommel; Joseph Rausch; Elizabeth K Towner; Joan Schall; Asim Maqbool; Maria Mascarenhas; Virginia Stallings
Journal:  J Pediatr Nurs       Date:  2019-04-18       Impact factor: 2.145

Review 2.  Update on key emerging challenges in cystic fibrosis.

Authors:  Mark T Jennings; Kristin A Riekert; Michael P Boyle
Journal:  Med Princ Pract       Date:  2014-01-10       Impact factor: 1.927

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.